{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Emerging Markets Report: A Psychedelic Story - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"FgmLuDd86O\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-a-psychedelic-story\/\">Emerging Markets Report: A Psychedelic Story<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-a-psychedelic-story\/embed\/#?secret=FgmLuDd86O\" width=\"600\" height=\"338\" title=\"&#8220;Emerging Markets Report: A Psychedelic Story&#8221; &#8212; Market Newsdesk\" data-secret=\"FgmLuDd86O\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 09, 2021 (GLOBE NEWSWIRE) &#8212; Last month we introduced our readership to XPhyto Therapeutics Corp. (XPHYF). At such time, we mentioned that the Company is also involved in psychedelics and that we would dive into that matter at a later date. Today\u2019s that date. For the uninitiated, psychedelic companies have been enjoying increased interest in North American stock markets as research portends significant possible clinical use. Take a look at this article from Forbes. Here\u2019s a brief excerpt: \u201cLike cannabis, the psychedelics industry has been growing at a locomotive pace. A key reason is an intriguing trend within the mental health community: the evolving acceptance of psychedelic drugs for treating depression and &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjUxNyM0MDU0MzAxIzUwMDA3ODA1Ng=="}